The pneumococcal vaccine market is expected to show considerable growth at a CAGR of around 4.0% during the forecast period 2020-2026. Major factors for the growth of the market include high spending to curb pneumonia among children in the developed economies. Moreover, increasing healthcare infrastructure in the emerging economies, rising per capita healthcare expenditure, and […]
